Article
A Novel Bispecific Antibody Targeting Frizzled7 and PD-L1 Reverses Immunotherapy Resistance in Non-Small Cell Lung Cancer by Reprogramming the Tumor Microenvironment
2026-04-29
Abstract excerpt
<title>Abstract</title> <p> Immunotherapy efficacy in non-small cell lung cancer (NSCLC) remains limited, largely due to aberrant activation of the Wnt/β-Catenin pathway. However, the precise role of its receptor Frizzled7 (Fzd7) in immune checkpoint inhibitor (ICI)-resistance remains unexplored. Here, we elucidate the role of Fzd7 in shaping the immunosuppressive tumor microenvironment (TME) and develop a novel...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 61eadd3f-7d7e-5172-b691-bdb1bfd95812
- DOI
- 10.21203/rs.3.rs-9337927/v1
